Fanwei Huang
1095 JieFang Avenue
Wuhan, 430030, China
Wuhan, 430030, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Development and preclinical evaluation of KDTV001, an adenovirus 5-vectored trivalent HPV therapeutic vaccine targeting HPV16/18/52.
Journal: EBioMedicine
Published: September 22, 2025
A P4HA2 hypoxia signature derived from single cell atlas stratifies conserved subtypes with prognostic significance in cervical squamous cell carcinoma.
Journal: BMC cancer
Published: June 06, 2025
HPV integration: a precise biomarker for detection of residual/recurrent disease after treatment of CIN2-3.
Journal: Infectious agents and cancer
Published: April 10, 2024
Natural small molecule compounds targeting Wnt signaling pathway inhibit HPV infection.
Journal: Microbial pathogenesis
Published: January 24, 2024
HPV integration status conversion and CIN2 + cancer risk stratification based on HPV integration levels among HPV integration-positive women: a 1-year follow-up study.
Journal: BMC cancer
Published: January 01, 2024
Extracellular vesicles hybrid plasmid-loaded lipid nanovesicles for synergistic cancer immunotherapy.
Journal: Materials today. Bio
Published: August 08, 2023
Testing for viral DNA integration among HPV-positive women to detect cervical precancer: An observational cohort study.
Journal: BJOG : an international journal of obstetrics and gynaecology
Published: November 03, 2022
Syntaxin-17-Dependent Mitochondrial Dynamics is Essential for Protection Against Oxidative-Stress-Induced Apoptosis.
Journal: Antioxidants (Basel, Switzerland)
Published: September 25, 2019
Showing 1-8 of 8
Last Updated: 09/26/2026